Background There are concerns about effects of lactation on postpartum weight changes among HIV-infected women because low weight may increase risks of HIV-related disease progression.
Introduction
Among healthy women, breastfeeding is recommended as a means towards more rapid return to pre-pregnancy weight.
1,2 However, for HIV-infected women, especially those who are ill or marginally nourished, weight loss could compromise health status. The energy requirements of lactation combined with the metabolic burden of HIV infection has the potential to lead to maternal nutritional depletion. 3 Furthermore, weight loss and lower body mass index (BMI) are associated with HIV disease progression. [4] [5] [6] [7] [8] [9] [10] Published literature pertaining to the effects of lactation on postpartum weight is contradictory. Studies among healthy populations report that weight change during lactation widely varies between populations and between individuals. [11] [12] [13] Among women who are poorly nourished, studies report either no weight loss or moderate weight gain. 13 Studies assessing weight change among HIV-infected women during lactation are sparse and findings are inconsistent. Two studies found an association between breastfeeding and weight loss 14, 15 and one found no association. 16 In a study conducted in Rwanda, postpartum weight gain was reported among breastfeeding HIV-infected women; however, these gains were less than those observed among HIV-uninfected women. 17 Maternal metabolism during lactation is not entirely understood. 11, [18] [19] [20] [21] Studies designed to quantify the energy costs of milk production and studies of the basal metabolic rate during lactation report conflicting results. 18, 19, 21, 22 Hartmann et al. describe the development of a homeorhetic model to explain metabolic adaptations supporting a dominant physiological state such as lactation. 19 Unlike homeostasis, which regulates chemical functions within seconds or minutes, homeorhesis regulates such functions over hours or days. While weight loss might be expected given the energy requirements of lactation, not all evidence supports this, and, notably, some undernourished populations gain weight during lactation. 13, 19 Homeorhesis may explain this apparent discrepancy, as the body prioritizes milk production and limits typical homeostatic responses.
The objective of this study was to examine maternal weight change patterns from the 4th through the 24th month postpartum among HIV-infected women enrolled in a study in Lusaka, Zambia. 23 The study was a randomized clinical trial of shortened breastfeeding for reducing breastfeeding-associated transmission of HIV and infant mortality. Women were randomized to breastfeed for either 4 months or for a duration of their own choosing. Because low BMI has been shown to be associated with HIV-disease progression 8 and mortality, 9 and low CD4 count is a powerful laboratory marker of disease progression, we analysed the risk of weight loss in these high-risk groups separately. We aimed to determine if continued breastfeeding increases the risk of depletion in these high-risk women. We hypothesized that given the evolutionary importance of breastfeeding, homeorhetic mechanisms would protect these women and minimize effects of lactation on weight loss.
Methods

Study population
This is a secondary analysis of data collected as part of a clinical trial in Lusaka, Zambia. 23 Briefly, between May 2001 and September 2004, 958 HIVinfected pregnant women who intended to breastfeed were enrolled and later randomized to one of two breastfeeding groups: a short-duration group, in which women were counselled to exclusively breastfeed and abruptly stop at 4 months; or a longer duration group, in which women were encouraged to exclusively breastfeed up to 6 months, and wean as per their own informed preference. Median duration of breastfeeding in this group was 16 months. Women were followed for 24 months postpartum. All women provided signed informed consent for participation and the study protocol was approved by the institutional review boards at the investigators' institutions in the USA and Zambia.
Height, weight, CD4 T-cell count (FACSCount, BD Sciences), viral load (Amplicor HIV-1 Monitor Test, Roche), and haemoglobin (HemoCue System, HemoCue) measures were collected at the first prenatal visit. Maternal weight and information about infant feeding practices were collected at each study visit beginning 1 week postpartum, then monthly for 6 months and every 3 months thereafter. Infant feeding practice information was obtained from mothers by different members of the study staff from those performing the counselling. Breastfeeding duration was defined as the time from birth until the exact age that breastfeeding was first reported to have stopped. Information about hospitalizations and deaths of mother or child were collected from hospital records and family members. Data from women who became pregnant, died, or who were lost during follow-up were retained in the analysis until the event occurred and then were censored. Weight measured at 4 months postpartum was used as the baseline weight for this analysis, as this is the time when breastfeeding practices diverged between the two randomized groups. It is only after 4 months that we would expect the effects on weight of longer duration breastfeeding to emerge. If a 4-month weight measurement was not available, the closest previously collected weight was substituted; the earliest substitution was 1 week postpartum. We included in this analysis 768 women retained in the study and surviving to 4 months postpartum with a baseline weight and at least one post-4-month weight measurement.
Study outcomes
The study outcomes were mean weight in kilograms (kg) and percent of women underweight [<18.5 BMI (kg/m 2 )] as defined by the World Health Organization (WHO). 24 Weight in kilograms is a readily recognizable continuous outcome, particularly when discussing small differences between groups. However, BMI is an important categorical indicator of overweight and underweight, and for this reason we included this outcome to assess the risk of underweight, or BMI < 18.5.
Risk factors
The primary objective was to evaluate the association between breastfeeding duration and the study outcomes.
Breastfeeding status was classified as-randomized (intent-to-treat), i.e. long-duration or short-duration groups. Additionally, 'as-practiced' (as-treated) analysis was also conducted. In as-practiced analysis, breastfeeding was classified as short duration if all breastfeeding stopped before 5 months (152 days) or long duration if breastfeeding continued. Baseline BMI and CD4 T-cell count were examined as independent risk factors and potential effect modifiers. Baseline BMI was calculated using baseline weight (4 months postpartum) and height at enrolment, and was categorized into low (<18.5) and high (518.5). CD4 T-cell count as measured at enrolment was categorized into low (4350 cells/ml) and high (4350 cells/ml). One participant did not have a baseline CD4 count and the 12-month measure was used instead.
Statistical analysis
First, the mean maternal weight was compared between the groups at each study visit separately, from 6 through 24 months. Next, mixed linear models were used to examine group effects on maternal weight across all visits. A Toeplitz correlation structure, similar to an autoregressive model but less restrictive, was assumed. 25 Regression models were adjusted for baseline weight, as we observed a slight (non-significant) difference in baseline weight between the groups. To compare the risk of underweight (i.e. BMI < 18.5) in the two groups, first the proportions were examined at each visit separately testing for differences using chi-squared tests and odds ratios (ORs) calculated with logistic regression. Next, generalized estimating equations (GEE) were used to compare the proportions between the groups across all visits. An autoregressive correlation was assumed. Time was included in both mixed linear and GEE models as a covariate measuring months from baseline.
To examine whether low BMI and low CD4 count modified the association of breastfeeding duration with maternal weight, the analysis described above was repeated, stratified by (i) high and low baseline BMI and (ii) high and low CD4 count. Formal tests for effect modification within the mixed linear and GEE models were conducted using interaction terms: low baseline BMI Â long-duration breastfeeding; and low baseline CD4 Â long-duration breastfeeding.
Analysis of bias
We analysed four sources of potential bias. First, because adherence to the random assignment was incomplete, analyses were also conducted as-practiced, using reported breastfeeding less than or greater than 152 days. Secondly, we investigated a number of potential confounders, including variables related to maternal health, socio-economic status (SES), obstetric history, season, 26 and a food shortage resulting from a maize price increase that has been previously described to have affected health indicators in Lusaka. 27 A scale was created based on the sum of eight SES indicators, which were: availability of running water in the home; electricity, stove or refrigerator in the house; mother reports that she can read English very well, or that she can understand spoken English very well; mother has completed 57 years of school; and baby's father is employed (Cronbach's alpha ¼ 0.75). From this scale, a dichotomous variable was created for low SES (three or fewer SES indicators). All variables with P-values <0.20 in univariate regression analyses were considered for inclusion as covariates in adjusted models. Variables were added one by one to identify their impact in the presence of other covariates and to assess colinearity.
Thirdly, to address the concern that more postpartum weight loss may occur before 4 months than after, we performed analyses using 1 month as the baseline. Finally, we also analysed the sample without mothers who died during the study, then without mothers who had a child die during the study.
These women presumably had more advanced disease, weighed less throughout the study period, and were unable to attend all study visits.
All statistical analysis was performed in SAS 9.1 (SAS Institute, Inc.).
Results
Of 958 women randomized in the study, 768 are included in this analysis ( Figure 1 ). Women included in this analysis assigned to the short-duration breastfeeding group were similar in SES characteristics and HIV disease indicators to women assigned to the longduration breastfeeding group (Table 1) . Fewer than 7% of the full sample reported having a water tap inside the home, and 35% reported using a stove or hotplate for cooking rather than charcoal, wood or other cooking facilities. Over 20% of both groups reported their families had run completely out of food at least once in the past month. The mean baseline BMI was 21.7 among women in the short duration group, and 21.3 in the long duration group; 18.5 and 17% in the short and long duration groups, respectively, were underweight (<18.5 BMI) at baseline. At 4 months (baseline), women assigned to the long-duration breastfeeding group weighed slightly less [À1.3 kg, 95% confidence interval (CI): À2.7 to þ0.1; P ¼ 0.07] than women assigned to the short duration group; this difference was also present at 1 month postpartum (À1.3 kg, 95% CI: À2.7 to 0.0; P ¼ 0.06) (data not shown). Two hundred and fifty (66%) women in the short-duration group ceased breastfeeding within 5 months as assigned, whereas 129 (34%) continued beyond 5 months. Thirty-two (8%) women in the long-duration group ceased breastfeeding prior to 5 months, with an overall median duration of breastfeeding of 16 months in this group. The mean postpartum weight in the entire sample followed a U-shaped curve (data not shown), beginning with a mean weight at 1 week postpartum of 57.1 kg (95% CI: 56.4-57.9), decreasing to 55.2 kg (95% CI: 54.5-55.9) at 4 months postpartum, and increasing at 9 months, with a final mean weight of 57.3 kg (95% CI: 56.4-58.2) at 24 months. Likewise, the mean BMI at 1 week was 22.2 (95% CI: 22.0-22.5), at 4 months was 21.5 (95% CI: 21.2-21.7) and at 24 months was 22.3 (95% CI: 22.0-22.6). The proportion of women in the sample with a BMI <18.5 at each visit reflected this curve: 12.1% were <18.5 at 1 week postpartum, 18.1% at 4 months and 13.9% at 24 months.
Breastfeeding duration and postpartum weight On average, women in the long-duration group gained 1.0 kg (95% CI: 0.3-1.7) from 4 to 24 months compared with 2.3 kg (95% CI: 1.6-2.9) in the shortduration group (P ¼ 0.01). (Table 2 and Figure 2a) The corresponding increase on a BMI scale was 0.4 for women in the long-duration group (95% CI: 0.1-0.6) and 0.9 for the short-duration group (95% CI: 0.6-1.1) (P ¼ 0.01). The prevalence of being underweight was similar in both groups with the only difference detected at the 12-month visit. At baseline, 18% in the short and 17% in long-breastfeeding group were underweight (P ¼ 0.59), dropping to 14% in both groups (P ¼ 0.83) at 24 months. (Table 2 and Figure 2b ). Cumulatively, 30% in the short-and 33% 958 women enrolled in the ZEBS study 768 women included in this analysis 190 excluded: 49 mothers re-enrolled in the study with a repeat pregnancy; only the first pregnancy/birth was retained 46 lost to follow-up prior to 6 months 25 died prior to 6 months 70 did not have both baseline weight and at least one follow-up weight 379 assigned to short-duration breastfeeding (encouraged to stop breastfeeding at 4 months) 389 assigned to long-duration breastfeeding (breastfeeding for a median of 16 months) in the long-breastfeeding group were underweight at one or more follow up visits after 4 months (P ¼ 0.45). Overall, women in the long-duration breastfeeding group weighed less than the short-duration group from 6 through 24 months after adjusting for baseline weight and time since delivery (À1.0 kg, 95% CI: À1.5 to À0.5; P < 0.01) ( Table 3 ). In contrast, no association was found between longer breastfeeding and being underweight i.e. BMI < 18.5 (OR 1.1; 95% CI: 0.8-1.5; P ¼ 0.53).
Figure 1 Zambia Exclusive Breastfeeding Study (ZEBS) enrolment and inclusion in this analysis
Low baseline BMI (<18.5)
Women with low BMI at baseline, by definition, weighed less relative to height than those with higher BMI; however, when considering changes in weight over time, low BMI was associated with more weight gain (2.1 kg, 95% CI: 1.3-2.9; P < 0.01) across all follow-up visits (Table 3) . Differences in weight change between long-and short-duration breastfeeders were similar between women with low or higher BMI at baseline.
Low baseline CD4 (<350 cells/ml)
Lower CD4 count was associated with lower weight (À0.5 kg, 95% CI: À1.1 to 0.0; P ¼ 0.06) and an increased risk of being underweight (OR 1.9, 95% CI: 1.4-2.7; P < 0.01) ( Table 3 ). The effect of breastfeeding on weight change from 4 through 24 months did not differ between women with CD4 cell counts above and below 350.
Potential risk factors for postpartum weight
In addition to the primary risk factors of interest discussed above, we observed several other factors associated with postpartum weight (Table 4) . To estimate the effect of these factors on weight after 4 months through 24 months, we adjusted for any differences in weight at 4 months by including baseline weight as a covariate in linear regression models. Time (in months) from 4 months postpartum was associated with increased weight on a continuous scale, with weight increasing 0.1 kg per month on average (95% CI: 0.1-0.1; P < 0.01) in a mixed linear model including all study visit from 6 through 24 months.
Higher viral load at enrolment was associated with slightly lower weight: each log (base 10) increase in viral load was associated with 0.4 kg lower weight (95% CI: À0.7 to À0.1; P ¼ 0.02) after adjusting for baseline weight; additionally, each log increase in viral load was associated with an increased risk of underweight (OR 1.7, 95% CI: 1.4-2.2; P < 0.01). As a categorical variable, high viral load (4100 000 copies/ml) was not associated with weight on a continuous scale but was associated with being underweight (OR 2.0, 95% CI: 1.5-2.8). Some participants had access to antiretrovirals during the later years of the study period: 100 women, or 13.0%, reported starting antiretroviral therapy before the end of the study period. Antiretroviral use was not associated with weight on a continuous scale but did have a protective association with underweight (OR 0.6, 95% CI: 0.4-0.9; P ¼ 0.03). The dry season (MaySeptember) was associated with higher weight (0.5 kg, 95% CI: 0.3-0.6; P < 0.01) than the rainy season (October-April) and was not associated with being underweight (OR 0.9, 95% CI: 0.8-1.0; P ¼ 0.19). During the food shortage resulting from the national maize price increase from January 2003 through April 2004, we observed decreased weight (À1.0 kg, 95% CI: À1.4 to À0.6; P < 0.01) and an increased risk of being underweight (OR 1.8, 95% CI: 1.4-2.3). Nearly half (43%) of all study participants attended at least one study visit during this period. Among these women this privation lasted for a median duration of 5 months (inter-quartile range 2-8 months), and primarily occurred during the first year postpartum (78%). We examined the association of breastfeeding within the following subgroups: high and low viral Mixed linear models are used for the continuous outcome (weight in kg), and GEE are used for the dichotomous outcome, underweight. All models include all visits after 4 months and are adjusted for time since delivery. Mixed linear models are also adjusted for baseline weight. c Subgroups represent women in low-and higher BMI and CD4 count categories as measured at baseline. n/a ¼ not applicable.
LACTATION-ASSOCIATED POSTPARTUM WEIGHT CHANGES
load, rainy and dry seasons, and during the food shortage vs other times. Viral load and season did not modify the association of breastfeeding duration and weight. The food shortage, on the other hand, did modify the effect of breastfeeding on weight, such that during the food shortage, breastfeeding had no effect on weight on a continuous scale (À0.3 kg, 95% CI: À1.2 to 0.5); at all other times, breastfeeding was associated with lower weight (À1.2 kg, 95% CI: À1.7 to À0.6) (P ¼ 0.03 for interaction term).
Potential biases
Associations between longer duration breastfeeding and maternal weight were similar in the as-practiced analyses compared with the intent-to-treat analyses presented above. Long duration breastfeeding was associated with lower weight (À0.7 kg, 95% CI: À1.3 to À0.1; P ¼ 0.01) but was not associated with being underweight (OR 1.1, 95% CI: 0.8-1.5; P ¼ 0.68) (data not shown). Models were adjusted for time since delivery and low baseline CD4. Additionally, the mixed model used to estimate weight was adjusted for baseline weight and low baseline BMI.
To address the concern that more postpartum weight loss may occur before 4 months than after, we also performed analyses using 1 month as a baseline. Both groups lost weight between 1 month and 4 months with no difference in quantity lost (À0.89 kg in the short-duration group, 95% CI: À1.2 to À0.6; and À0.65 in the long-duration group, 95% CI: À1.1 to À0.2; P ¼ 0.47). On average, this weight was regained in both groups by 24 months. In models including all study visits after the first month through 24 months, long-duration breastfeeding was associated with less weight (À0.7 kg, 95% CI: À1.1 to À0.3; P < 0.01) and remained unassociated with BMI < 18.5 (OR 1.0, 95% CI: 0.8-1.4; P ¼ 0.83). We also analysed the sample excluding mothers who died during the study, then excluding mothers who had a child die during the study. Results based only on surviving mothers were slightly shifted towards the null compared with the full sample. Excluding child deaths resulted in a slightly greater attenuation of results. Among women with surviving children, longer breastfeeding was associated with À0.7 kg lower weight (95% CI: À1.3 to À0.1; P ¼ 0.02). Women who experienced a child die had lower baseline CD4 counts, lower baseline BMI and ceased breastfeeding (as-practiced) earlier than women who did not. In models assessing breastfeeding as-practiced and adjusted for these differences, the association of longer breastfeeding and weight does not differ between those who experienced a child death and those who did not. Mixed linear models are used for the continuous outcome. All models are adjusted for baseline weight and time since delivery. The beta coefficient represents the estimated change in weight (kg) for each unit change in the effect, across all visits from 6 through 24 months after adjusting for time since delivery and baseline weight. Time was significant in all models and thus was retained. Furthermore, time was tested for interaction with each effect and no significant interaction was found. b GEE are used for the dichotomous outcomes. All models are adjusted for time since delivery, which is significant in all models. No significant interaction with time was detected. c Low SES is defined as 43 of the following indicators: the baby's mother has a water tap, electricity, stove or refrigerator in the house; she can read or understand spoken English very well; she has completed 57 years of school; and the baby's father is employed. ARV ¼ antiretroviral.
Discussion
Weight loss among HIV-infected men, and women outside the postpartum period, is associated with increased mortality, [4] [5] [6] [7] 10 and low BMI is associated with HIV disease progression 8 and mortality. 9 Though it is generally believed that lactation promotes weight loss, the evidence for this, particularly in metabolically stressed or undernourished populations, is limited. 13, 19 In this study of HIV-infected breastfeeding women in a low-resource setting, more women gained than lost weight from 4 to 24 months postpartum, but longer duration breastfeeding was associated with less weight gain. Despite this association, longer duration breastfeeding was not associated with an increase in the risk of becoming underweight, i.e. having a BMI < 18.5.
Few studies have assessed postpartum weight changes in HIV-infected women, and inconsistencies in methodology in these studies make results difficult to synthesize and interpret as a whole. The time periods for evaluation vary from a few months to 2 years postpartum and the classification of breastfeeding also lacks consistency in terms of duration and exclusivity. Two studies assessing weight change up to 6 months postpartum in lactating women found slower weight gain 17 or weight loss 15 in HIV-infected women compared with HIV-uninfected women. A randomized trial in Kenya found more postpartum weight loss among breastfeeding women than formula feeding women from the earliest postnatal visit up to 5-9 months. 3 A cohort study found a slightly more rapid decline in BMI from 1 to 24 months postpartum associated with breastfeeding compared with formula feeding. 14 Another cohort found no difference in the risk of 10% weight loss after 6 or 9 months postpartum between breastfeeding and non-breastfeeding women. 16 Here we see mix of weight gain and loss postpartum, and the effect of lactation on weight appears inconclusive.
The energy cost of lactation could be met through increased dietary intake, reduced physical activity, mobilization of maternal energy reserves or metabolic adaptations. 18, 19 The metabolic adaptations during lactation are complex and highly variable. While we cannot rule out the possibility of increased dietary intake or reduced physical activity in our sample, poor women have limited ability to increase their diet or to reduce their physical workload. Notably, 420% of our sample reported at enrolment running completely out of food at least once in the last month. Studies measuring change during lactation in the basal metabolic rate or in diet-induced thermogenesis show inconsistent results, though generally there is little or no change. 18, 19, 22 Measuring change in diet-induced thermogenesis is particularly challenging due to the degree of individual variation and changes in diet over time. 22 An alternative explanation to what appears to be energy sparing in undernourished breastfeeding women could be reductions in lactation related energy expenditures, either through reductions in milk synthesis or in the nutrient content of breast milk. However, most studies do not find the quantity of milk production to be compromised, though some studies of underweight women show small reductions in fat or nutrient content. [28] [29] [30] The effect of chronic stress, whether from malnutrition or disease, on metabolism during lactation is not extensively studied. In an effort to better understand metabolism during lactation in undernourished women, milk production has been quantified during Ramadan, a holy month in the Islamic calendar observed with 30 days of daytime fasting, 31 and during a 24-h fast. 20 While both studies confirmed no effect on the quantity of milk production, neither scenario adequately represents chronic undernourishment. In our study, the difference in weight change associated with breastfeeding was small, only 1 kg difference from 4 months through 24 months. If we consider a conservative estimate of the shortduration breastfeeding group stopping breastfeeding at 5 months, the long-duration group stopping at 16 months (the median), and provision of 350 kcal/ day of breast milk during these 11 months (based on a pooled analysis by the WHO on the quantity of milk consumed by infants between 12 and 23 months in developing countries 32 ) in the long duration group, the difference in weight of only 1 kg 420 months denotes considerable energy conservation.
A homeorhetic model of metabolism, which addresses long-term response to a dominant physical state rather than the minute-by-minute responses of homeostasis, offers the explanation that in an undernourished lactating woman, the synthesis of milk becomes the priority as the dominant physical state, and energy reserves are protected. 19 Our finding of overall weight gain, particularly in those with lower baseline BMI, suggests such metabolic adaptations. Furthermore, the small magnitude of the association of breastfeeding with lower weight in our sample and the finding that breastfeeding was not associated with weight loss during the food shortage both support this explanation.
This study has a number of potentially important limitations. First, the proportion of women who did not adhere to their randomized assignment was large. With 34% of the short duration group continuing breastfeeding beyond 5 months, we would expect this misclassification in as-randomized analyses to bias the results toward the null. Despite the incomplete adherence, there were large enough differences in breastfeeding duration between the groups to detect differences in post-partum weight. Additionally, results of as-practiced analysis were similar to those from the intent-to-treat analysis. Among women assigned to the short-duration group, those who chose to continue breastfeeding beyond 5 months had higher baseline BMI, higher baseline CD4 counts, and were more likely to have low SES than those who adhered. Statistical adjustment for these factors in as-practiced analyses did not change the results.
Secondly, we have limited data on additional variables that may be important to postpartum changes in weight. Measurements that could enhance this analysis include: pre-pregnancy weight, rate and amount of weight gain during pregnancy, changes in diet, changes in activity, and daily frequency of breastfeeding after 6 months. A related issue is measuring 'underweight' with an international standard (BMI < 18.5) as the sensitivity and specificity of this measure may vary across cultures. 33 Additionally, while this study measures the effect of extended breastfeeding compared with short-duration breastfeeding, we cannot compare these results with non-breastfeeding women. Similarly, we cannot directly compare these results to postpartum weight change in HIV-uninfected women, though in reported studies, we have noted that results measuring postpartum weight change widely vary. [11] [12] [13] This trial was conducted before widespread access to antiretroviral therapy when early cessation of breastfeeding was still being considered as a possible strategy to reduce HIV transmission. In 2009, the WHO revised their infant feeding guidelines, encouraging HIV-infected women to breastfeed to 12 months and to treat those with low CD4 counts with antiretroviral therapy. Given today's context, further study of interventions for the prevention of HIV transmission to the child in the context of continued breastfeeding is essential. Both cohort studies and randomized trials of antiretrovirals for the mother and infant postpartum show promising results. [34] [35] [36] [37] [38] [39] [40] [41] [42] Further study of maternal health associated with continued breastfeeding in the era of antiretroviral therapy for the mother is warranted.
The results from our analysis suggest that longduration breastfeeding does not present an important risk to maternal health of HIV-infected women in terms of promoting postpartum weight loss. Based on these results, together with prior analyses from the same cohort observing no association between breastfeeding and maternal mortality, 43 we conclude that long-duration breastfeeding does not appear to increase risks of wasting likely to be detrimental to HIV disease progression. 
